<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Between 1968 and 1975, 44 evaluable children under 16 years of age with the histologic diagnosis of non-Hodgkin malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (ML) were treated at the Istituto Nazionale Tumori of Milan </plain></SENT>
<SENT sid="1" pm="."><plain>Histologic diagnoses were reclassified as follows: 13 lymphoblastic (others) ML, 15 convoluted cell type lymphoblastic ML, 9 Burkitt type ML, and 7 immunoblastic ML </plain></SENT>
<SENT sid="2" pm="."><plain>Only 36% of the patients had stage I and II disease </plain></SENT>
<SENT sid="3" pm="."><plain>At diagnosis 25% showed malignant cells in the bone marrow smears </plain></SENT>
<SENT sid="4" pm="."><plain>Bone marrow infiltration was particularly frequent in the convoluted cell type lymphoblastic ML and in the lymphoblastic (others) ML subgroups </plain></SENT>
<SENT sid="5" pm="."><plain>Burkitt type ML frequently was associated with abdominal lesions and subsequently a high incidence of central <z:mp ids='MP_0008912'>nervous</z:mp> system involvement </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with stage I and II ML were encountered mostly in the <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> ML subgroup </plain></SENT>
<SENT sid="7" pm="."><plain>After 1973 more intensive chemotherapy plus radiotherapy seems to have slightly improved the survival of the patients, except in the Burkitt type ML Subgroup </plain></SENT>
</text></document>